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Abstract 1 
Objective: Metabolic syndrome and the presence of metabolic syndrome components 2 
are risk factors for cardiovascular disease (CVD). However, the association between 3 
personality traits and metabolic syndrome remains controversial, and few studies have 4 
been conducted in East Asian populations.  5 
Methods: We measured personality traits using the Japanese version of the Eysenck 6 
Personality Questionnaire (Revised Short Form) and five metabolic syndrome 7 
components—elevated waist circumference, elevated triglycerides, reduced 8 
high-density lipoprotein cholesterol, elevated blood pressure, and elevated fasting 9 
glucose—in 1,322 participants aged 51.1±12.7 years old from Kakegawa city, Japan. 10 
Metabolic syndrome score (MS score) was defined as the number of metabolic 11 
syndrome components present, and metabolic syndrome as having an MS score of 3 or 12 
higher, in accordance with the American Heart Association/National Heart, Lung, and 13 
Blood Institute Scientific Statement. 14 
Results: Mean (± standard deviation) personality scores were higher in participants with 15 
(N=241) than without metabolic syndrome (N=1,081): 6.1±3.2 vs. 5.6±3.1 for 16 
“extraversion”, 3.0±1.6 vs. 2.8±1.6 for “psychoticism”, 6.7±2.5 vs. 6.1±2.7 for “lie”, 17 
respectively (all P<0.05). In multiple regression analyses adjusted for age, sex, 18 
education, income, smoking status, alcohol use, and family history of CVD and diabetes 19 
mellitus, only “extraversion” was associated with MS score (coefficient=0.12, P=0.0003). 20 
In multiple logistic regression analysis with the same adjustments, “extraversion” was 21 
also positively associated with metabolic syndrome (odds ratio = 1.13, 95% confidence 22 
interval = 0.97–1.31; P=0.1). 23 
Conclusions: Higher “extraversion” scores tended to be related to a higher prevalence 24 
of metabolic syndrome and higher MS scores.  25 
Keywords: A cross-sectional study; extraversion; the metabolic syndrome;  26 
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Introduction 1 
Metabolic syndrome involves a number of risk factors for cardiovascular disease (CVD) 2 
and type 2 diabetes mellitus (DM), including dysglycemia, elevated blood pressure, 3 
elevated triglycerides, reduced high-density lipoprotein cholesterol (HDL-C) levels, and 4 
obesity[1]. In a meta-analysis, metabolic syndrome was shown to increase the risk of 5 
cardiovascular mortality by two-fold and of all-cause mortality by 1.5-fold[2]. The 6 
number of metabolic syndrome components present is also related to coronary artery 7 
disease[3–5]. Additionally, it has been reported that metabolic syndrome and the 8 
number of components in Japanese individuals are related to cardiovascular and 9 
all-cause mortality[6]. In Japan, CVD is the second most common cause of death after 10 
malignancy[7]. Therefore, it is important to determine risk factors for metabolic 11 
syndrome and the number of components. Several risk factors, including smoking 12 
status[8], alcohol use[9], and family histories of DM[10] and CVD[11], have been well 13 
investigated as risk factors for metabolic syndrome; psychological factors have also 14 
been reported to be related to CVD[12]. 15 
“Neuroticism” and “extraversion” are well-known personality traits[13] that have 16 
been shown to have an impact on cardiovascular risk and mortality; “neuroticism” is 17 
related to the risk of death from CVD[14], and is associated with the risk of coronary 18 
heart disease[15], while “extraversion” is associated with the risk of stroke[15]. However, 19 
in several studies, no association was found between personality traits and all-cause 20 
mortality[16, 17], or between ischemic heart disease and stroke[18]. “Neuroticism” and 21 
“extraversion” are also associated with some metabolic syndrome components. In 22 
Japanese individuals, “neuroticism”, “extraversion”, and “psychoticism” are associated 23 
with obesity [19], while “extraversion” is positively related to systolic blood pressure[20]. 24 
Therefore, we assumed that metabolic syndrome is one of the pathways between 25 
personality traits and CVD. 26 
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Several studies, including a systematic review, investigated the relationship 1 
between personality traits and metabolic syndrome[21] in non-East Asian populations. 2 
Although the systematic review concluded that there was no clear association between 3 
personality traits and metabolic syndrome, some personality traits were found to be 4 
related to metabolic syndrome in individual studies[21]. Furthermore, to our knowledge, 5 
no such study has focused on East Asian populations. East Asian populations have 6 
different lifestyles from their non-East Asian counterparts, so the relationship between 7 
personality traits and metabolic syndrome in East Asians needs to be clarified in order to 8 
identify risk factors for metabolic syndrome. 9 
Therefore, the aims of the present study were to investigate the relationship 10 
between personality traits and metabolic syndrome/the number of components in 11 
Japanese individuals, and to examine the relationship between personality traits and 12 
metabolic syndrome components. 13 
 14 
Methods 15 
Participants and procedure 16 
We conducted a cross-sectional study using baseline data from the Kakegawa cohort 17 
study, a prospective cohort study in Kakegawa city, Japan that was approved by the 18 
ethics review committee of Tohoku University (2009-150). Between June 2009 and 19 
October 2011, participants were recruited by a flyer inserted in the local newspaper. The 20 
inclusion criteria were age over 30 years and currently living in Kakegawa city. After 21 
receiving the flyer, people who were interested in joining the study contacted the authors 22 
by post, telephone, fax, or e-mail and made appointments for medical examinations. 23 
Next, we sent the respondents an explanation of the study, an informed consent form, a 24 
questionnaire, and a urine test kit by post. Informed consent was obtained from all of the 25 
participants at the health center after they received an explanation of the study 26 
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objectives and methods by trained staff. In total, 1,535 participants were enrolled. Two 1 
participants withdrew their consent, and 220 participants had some missing variables, 2 
such as basic characteristics, metabolic syndrome components, and scores on the 3 
Japanese version of the Eysenck personality questionnaire-revised, short form 4 
(EPQ-RS); these participants were excluded, leaving a total of 1,322 participants (831 5 
women; mean age ± standard deviation [SD]=51.1±12.7 years) for analysis. The study 6 
protocol was approved by the institutional review board of Tohoku University. 7 
We collected the questionnaires and urine samples, took blood samples, and 8 
measured height, weight, waist circumference, and blood pressure during the medical 9 
examinations. Blood pressure was measured twice, and the average of the two values 10 
was used. 11 
 12 
Definition of metabolic syndrome 13 
According to the American Heart Association/National Heart, Lung, and Blood Institute 14 
(AHA/NHLBI) Scientific Statement[22], metabolic syndrome was defined as the 15 
presence of three or more of the following five components: elevated waist 16 
circumference (≥90 cm for men, ≥80 cm for women); elevated triglycerides (≥150 mg/dL 17 
or on drug treatment for elevated triglycerides); reduced HDL-C (<40 mg/dL for men, 18 
<50 mg/dL for women or on drug treatment for reduced HDL-C); elevated blood 19 
pressure (≥130 mmHg systolic blood pressure or ≥85 mmHg diastolic blood pressure or 20 
on antihypertensive drug treatment in a patient with a history of hypertension); and 21 
elevated fasting glucose (≥100 mg/dL or on drug treatment for elevated glucose). Next, 22 
we calculated the metabolic syndrome score (MS score), which was defined as the 23 
number of metabolic syndrome components present (range, 0–5). 24 
 25 
Questionnaire 26 
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Participants completed a questionnaire regarding their age, sex, income, education, 1 
smoking status, alcohol use, personal history, medication history, and family history. We 2 
measured personality traits using the EPQ-RS[23]. The EPQ-RS has 48 items to which 3 
participants are asked to respond either “Yes” or “No”. The EPQ-RS measures the 4 
following four personality traits: “neuroticism”, “extraversion”, “psychoticism”, and “lie”. 5 
The score of each personality trait is calculated based on a 12-item scale, and thereby 6 
ranges from 0–12. In a previous study, the reliability and validity of the Japanese version 7 
of the EPQ-RS were confirmed[23]. 8 
 9 
Statistical analyses 10 
The participants’ characteristics and personality scores were compared between those 11 
with and without metabolic syndrome using the Student’s t-test for continuous variables 12 
and the chi-square test for categorical variables. 13 
To examine the relationship between personality and MS scores, we performed 14 
logistic regression analyses with changing the dichotomizing threshold of the MS score 15 
(1–5 vs. 0, 2–5 vs. 0–1, 3–5 vs. 0–2, and 4–5 vs. 0–3). Then, we used multiple logistic 16 
regression analyses considering the MS score subgroup as a dependent variable and 17 
the personality score as an independent variable. According to the AHA/NHLBI 18 
Scientific Statement, we considered metabolic syndrome as an outcome when the MS 19 
score was divided into 3–5 and 0–2[22]. In multiple logistic regression analyses, we 20 
adjusted for age (30–39, 40–49, 50–59, 60–69, and ≥70 years old), sex, education 21 
(junior high school, high school, junior college/vocational school/university dropout, and 22 
college/university or higher), income (≤5.99, 6.00–11.99, and ≥12.00 million JPY/year), 23 
smoking status (current, past, and never), alcohol use (current, past, and never), and 24 
family history of CVD (present, absent) and DM (present, absent). To examine the effect 25 
of each personality score on MS scores, multiple regression analyses were conducted 26 
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using each personality score as an independent variable and the MS score as a 1 
dependent variable. Moreover, we performed ordinal logistic regression analyses using 2 
each personality score as an independent variable and the MS score as a dependent 3 
variable on the condition that those with four or five components were in the same group, 4 
because the number of those with five components was too small for ordinal logistic 5 
regression analyses. In both multiple regression analyses and ordinal logistic regression 6 
analyses, we included the same variables described above for adjustment. 7 
We also investigated the association of each personality score with metabolic 8 
syndrome components. The differences in each personality score were then compared 9 
between those with and without metabolic syndrome components using Student’s t-test. 10 
We also performed multiple logistic regression analyses considering each personality 11 
score as an independent variable and an individual metabolic syndrome component as 12 
a dependent variable after adjusting for the confounders described above. Each 13 
personality score was standardized to the z-score in all multivariate analyses. 14 
We used the SAS package (version 9.4, SAS Institute Inc., Cary, NC, USA) for 15 
all analyses and considered P values <0.05 to be statistically significant. 16 
 17 
Results 18 
A total of 241 participants (18.2%) had metabolic syndrome. Compared with those 19 
without metabolic syndrome, those with metabolic syndrome were older (P<0.0001), 20 
more likely to be men (P=0.002), have a lower level of education (P<0.0001), and have 21 
a family history of CVD (P=0.03) or DM (P=0.01). Those with metabolic syndrome had 22 
lower “neuroticism” scores (P=0.06), higher “extraversion” scores (P=0.02), higher 23 
“psychoticism” scores (P=0.049), and higher “lie” scores (P=0.0003) than those without 24 
metabolic syndrome (Table 1). 25 
In the crude model (Table 2), “extraversion” (odds ratio [OR] = 1.18, 95% 26 
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confidence interval [CI] = 1.02–1.35; P=0.02), “psychoticism” (OR=1.15, 95% 1 
CI=1.00–1.32; P=0.049) and “lie” (OR=1.30, 95% CI=1.13–1.50; P=0.0004) were 2 
related to metabolic syndrome. In multiple logistic regression analyses (Table 2), 3 
“extraversion” was significantly related to the high MS score subgroup (1–5 vs. 0: 4 
OR=1.25, 95% CI=1.09–1.42, P=0.001; 2–5 vs. 0–1: OR=1.19, 95% CI=1.05–1.35, 5 
P=0.006; 4–5 vs. 0–3: OR=1.31, 95% CI=1.06–1.62, P=0.01), except when MS scores 6 
were divided into 3–5 and 0–2 (OR=1.13, 95% CI=0.97–1.31; P=0.1). “Psychoticism” 7 
was only related to the high MS score subgroup when MS scores were divided into 0–1 8 
and 2–5 (OR=1.15, 95% CI=1.01–1.31; P=0.03) (Table 2). In multiple regression 9 
analyses, “extraversion” was positively related to MS scores (coefficient=0.12, standard 10 
error=0.03; P=0.0003) (Table 3). The results of ordinal logistic regression analyses were 11 
similar to those of multiple regression analyses (data not shown). 12 
“Extraversion” scores were higher in those with metabolic syndrome 13 
components (elevated waist circumference: P=0.001; elevated triglycerides: P=0.01; 14 
reduced HDL-C: P=0.09; elevated blood pressure: P=0.004; elevated fasting glucose: 15 
P=0.002) (Table 4). In multiple logistic regression analyses, “extraversion” was related 16 
to elevated waist circumference (OR=1.20, 95% CI=1.06–1.36; P=0.003), elevated 17 
triglycerides (OR=1.19, 95% CI=1.02–1.38; P=0.02), elevated blood pressure (OR=1.16, 18 
95% CI=1.02–1.33; P=0.02), and elevated fasting glucose (OR=1.20, 95% 19 
CI=1.04–1.39; P=0.02). “Lie” was negatively related to elevated waist circumference 20 
(OR=0.83, 95% CI=0.72–0.94; P=0.004) (Table 4). 21 
 22 
Discussion 23 
“Extraversion” tended to be positively related to metabolic syndrome and was positively 24 
related to MS scores. We also found that high “extraversion” scores were related to 25 
metabolic syndrome components other than reduced HDL-C. “Neuroticism”, 26 
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“psychoticism”, and “lie” were not associated with metabolic syndrome or MS scores. It 1 
should be emphasized that no studies have investigated the relationship between 2 
personality traits, metabolic syndrome, and MS scores in East Asian populations. 3 
Our results were consistent with those of some studies in Japan that 4 
investigated the relationship between personality traits as measured by the EPQ-RS 5 
and metabolic syndrome components. In a cohort study involving 41,424 participants 6 
from Miyagi Prefecture, “extraversion” and “psychoticism” were positively associated 7 
with obesity, and “neuroticism” was negatively associated with obesity[19]. In the 8 
Ohasama study, morning blood pressure was measured in 999 people from the general 9 
population at home for 4 weeks[20]. The results showed that “extraversion” was 10 
positively associated with home blood pressure. The populations of our and previous 11 
studies were similar in that they were all Japanese and middle-aged and older; therefore, 12 
our study was consistent with these previous studies. 13 
Previous studies that have investigated the relationship between personality 14 
traits and metabolic syndrome in non-Japanese populations have reported results that 15 
conflicted with those in the present study; they reported that “neuroticism”, but not 16 
“extraversion”, tended to be positively associated with metabolic syndrome. In a study of 17 
4,208 men from the Vietnam Experience Study in the U.S.[24], “neuroticism”, as 18 
measured by the Minnesota Multiphasic Personality Inventory, was positively 19 
associated with metabolic syndrome. However, the population and measurements in 20 
that study differed from those in the present study; the Vietnam Experience Study 21 
consisted of only male military personnel from the U.S. Vietnam-era Army, and body 22 
mass index was used as one of the components of metabolic syndrome instead of waist 23 
circumference. Another study involving 2,419 participants from the SardiNIA project in 24 
Italy[25] reported that high “neuroticism”, but not “extraversion”, as measured by the 25 
Revised NEO Personality Inventory, was associated with metabolic syndrome. They 26 
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showed a similar prevalence of metabolic syndrome (19.2%) to our results (18.2%) 1 
because the participants were aged over 45 years, which is similar to our population in 2 
that all participants were middle-aged or older. Furthermore, the same definition of 3 
metabolic syndrome was used in both studies. We assume that the differences in the 4 
results between the SardiNIA project and our study were partly due to differences in the 5 
personality tests. 6 
Few studies have investigated the relationship between personality traits and 7 
MS scores in non-Japanese populations[26], and no studies have investigated this 8 
relationship in Japanese populations. In a previous study, 15,359 participants were 9 
recruited from the fourth wave of The National Longitudinal Study of Adolescent to Adult 10 
Health in the U.S. in 2008–2009[26]. Personality traits from the Mini International 11 
Personality Item Pool and four metabolic syndrome components (blood pressure, waist 12 
circumference, elevated cholesterol, and non-fasting blood glucose) were measured. 13 
The researchers defined a metabolic risk index as the sum of the components (range, 14 
0–4). The results showed that “neuroticism” was positively associated with metabolic 15 
syndrome components other than waist circumference and the metabolic risk index. 16 
“Extraversion” was not associated with any of the metabolic syndrome components or 17 
the metabolic risk index. One of the reasons for the differences between the results of 18 
our and the previous study is that there were differences in the definitions of some 19 
components used for analyses. Namely, ≥140 mmHg systolic blood pressure or ≥90 20 
mmHg diastolic blood pressure was considered hypertension in the previous study[26], 21 
while in our study, hypertension was considered ≥130 mmHg systolic blood pressure or 22 
≥85 mmHg diastolic blood pressure or on antihypertensive drug treatment for patients 23 
with a history of hypertension. 24 
The results of previous studies[24–26] involving non-East Asian populations 25 
that investigated the relationship between personality traits, metabolic syndrome, and 26 
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MS scores do not support the results of the present study; this is partly because of 1 
differences in personality tests or in the definition of metabolic syndrome components, 2 
as described above; however, racial differences should also be taken into consideration. 3 
No studies have been conducted on the relationship between personality traits and 4 
metabolic syndrome in East Asian populations. We demonstrated that “extraversion” 5 
tended to be positively related to metabolic syndrome. 6 
“Extraversion” may be related to metabolic syndrome through multiple 7 
pathophysiological mechanisms. “Extraversion” has been reported to be related to a 8 
high level of plasma cortisol[27], and cortisol is associated with metabolic syndrome[28, 9 
29]; therefore, the hypothalamic–pituitary–adrenal axis is a possible pathway. However, 10 
another study showed that “extraversion” was related to lower cortisol reactivity[30], so 11 
this pathway remains controversial. We also speculated that autonomic nervous 12 
function could be a possible pathway. “Extraversion” has been reported to be related to 13 
increased parasympathetic activity[31], and the vagus nerve has been shown to 14 
contribute to metabolic syndrome in rats[32]. Although these pathways may partially 15 
explain the relationship between “extraversion” and metabolic syndrome, personality 16 
traits can affect one’s health through health behaviors[33] or social relationships[34]; 17 
therefore, further studies are needed to clarify the mechanisms of the relationship 18 
between personality traits and metabolic syndrome. 19 
“Lie” scores were positively related to metabolic syndrome and MS scores in 20 
the crude model, but the opposite was found in the adjusted model because those who 21 
have a high “lie” score were older and more likely to be women; furthermore, the 22 
relationship between “lie” and age/sex is stronger than that of other personality 23 
traits[23]. 24 
Our results have at least three implications. First, personality tests, such as the 25 
EPQ-RS, are easy, noninvasive, and can be administered without any special 26 
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equipment or techniques. This means that we can easily introduce personality tests into 1 
clinical practice. It might be possible to use personality tests for screening to identify 2 
high-risk populations for metabolic syndrome in East Asian countries such as Japan. 3 
Second, identifying individuals with high “extraversion” scores among those who 4 
already have metabolic syndrome might be helpful to prevent CVD owing to more 5 
frequent and intensive health guidance. Finally, personality traits and metabolic 6 
syndrome are known as polygenetic[35, 36]. The relationship observed between 7 
personality traits and metabolic syndrome in this study may provide new insight into the 8 
identification of susceptibility genes for metabolic syndrome. 9 
The strength of this study is that it was the first study to investigate the 10 
relationship between personality traits, metabolic syndrome, and MS scores in an East 11 
Asian population. In addition, our sample was large with an adequate number of 12 
outcomes for analyses. However, this study did have some limitations. First, because 13 
this was a cross-sectional study, we could not determine whether personality traits or 14 
metabolic syndrome was the cause of the other. Second, even though our study 15 
included both sexes and a broad range of age groups, the participants took part in our 16 
study voluntarily, meaning that their health awareness could have been higher than the 17 
general population; therefore, the generalizability of the results is limited. 18 
In conclusion, higher “extraversion” scores were related to higher MS scores 19 
and tended to be related to a higher prevalence of metabolic syndrome.20 
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Table 1. Characteristics of the participants in the Kakegawa study by metabolic syndrome 
  
All 
(n=1,322) 
 
Metabolic syndrome 
 No (n=1,081) 
Yes 
(n=241)  
 
P 
Age, years      <0.0001 
30–39 323 (24.4)  311 (28.8) 12 (5.0)   
40–49 288 (21.8)  260 (24.1) 28 (11.6)   
50–59 288 (21.8)  225 (20.8) 63 (26.1)   
60–69 334 (25.3)  224 (20.7) 110 (45.6)   
≥70 89 (6.7)  61 (5.6) 28 (11.6)   
Women 831 (62.9)  701 (64.8) 130 (53.9)  0.002 
BMI, kg/m2 22.2 (3.1)  21.6 (2.7) 24.7 (3.3)  <0.0001 
Smoking status      0.1 
Current 146 (11.0)  114 (10.6) 32 (13.3)   
Past 314 (23.8)  249 (23.0) 65 (27.0)   
Never 862 (65.2)  718 (66.4) 144 (59.8)   
Alcohol use      0.4 
Current 806 (61.0)  668 (61.8) 138 (57.3)   
Past 29 (2.2)  22 (2.0) 7 (2.9)   
Never 487 (36.8)  391 (36.2) 96 (39.8)   
Education      <0.0001 
Junior high school 100 (7.6)  74 (6.9) 26 (10.8)   
High school 576 (43.6)  448 (41.4) 128 (53.1)   
Junior college, etc.a 330 (25.0)  293 (27.1) 37 (15.4)   
College/University or 
higher 316 (23.9)  266 (24.6) 50 (20.8)   
Income, million JPY/year      0.98 
≤5.99 845 (63.9)  690 (63.8) 155 (64.3)   
6.00–11.99 431 (32.6)  353 (32.7) 78 (32.4)   
≥12.00 46 (3.5)  38 (3.5) 8 (3.3)   
Family history of CVD 614 (46.4)  487 (45.1) 127 (52.7)  0.03 
Family history of DM 250 (18.9)  191 (17.7) 59 (24.5)  0.01 
Metabolic syndrome 
componentsb       
Elevated waist 
circumference 521 (39.4)  330 (30.5) 191 (79.3)  <0.0001 
Elevated triglycerides 239 (18.1)  64 (5.9) 175 (72.6)  <0.0001 
Reduced HDL-C 245 (18.5)  83 (7.7) 162 (67.2)  <0.0001 
Elevated blood pressure 500 (37.8)  307 (28.4) 193 (80.1)  <0.0001 
Elevated fasting glucose 264 (20.0)  129 (11.9) 135 (56.0)  <0.0001 
Personality score       
Neuroticism score 5.4 (3.0)  5.4 (3.0) 5.0 (3.0)  0.06 
Extraversion score 5.7 (3.1)  5.6 (3.1) 6.1 (3.2)  0.02 
Psychoticism score 2.8 (1.6)  2.8 (1.6) 3.0 (1.6)  0.049 
Lie score 6.2 (2.7)  6.1 (2.7) 6.7 (2.5)  0.0003 
Data are expressed as means (standard deviation) for continuous variables and n (%) for 
categorical variables. 
BMI: body mass index; CVD: cardiovascular disease; DM: diabetes mellitus; HDL-C: 
high-density lipoprotein cholesterol. 
aJunior college, vocational school, and university dropout. 
bElevated waist circumference: ≥90 cm for men, ≥80 cm for women; elevated triglycerides: ≥150 
mg/dL or on drug treatment for elevated triglycerides; reduced HDL-C: <40 mg/dL for men, <50 
mg/dL for women or on drug treatment for reduced HDL-C; elevated blood pressure: ≥130 
mmHg systolic blood pressure or ≥85 mmHg diastolic blood pressure or on antihypertensive 
drug treatment in a patient with a history of hypertension; elevated fasting glucose: ≥100 mg/dL 
or on drug treatment for elevated glucose.
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Table 2. Crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the relationship between each 
personality score and high MS scores (n=1322) 
 Crude OR 
 MS score 1–5 vs. 0 MS score 2–5 vs. 0–1 MS score 3–5 vs. 0–2b MS score 4–5 vs. 0–3 
Neuroticism 0.83 (0.74–0.93)† 0.84 (0.75–0.94)† 0.87 (0.76–1.01) 0.85 (0.70–1.04) 
Extraversion 1.27 (1.13–1.43)† 1.22 (1.09–1.37)† 1.18 (1.02–1.35)* 1.36 (1.12–1.66)† 
Psychoticism 1.05 (0.94–1.18) 1.13 (1.01–1.26)* 1.15 (1.00–1.32)* 1.12 (0.92–1.36) 
Lie 1.23 (1.09–1.38)† 1.22 (1.09–1.37)† 1.30 (1.13–1.50)† 1.37 (1.11–1.68)† 
     
 Adjusted ORa 
 MS score 1–5 vs. 0 MS score 2–5 vs. 0–1 MS score 3–5 vs. 0–2b MS score 4–5 vs. 0–3 
Neuroticism 0.93 (0.82–1.06) 0.93 (0.82–1.05) 0.99 (0.85–1.15) 0.95 (0.77–1.18) 
Extraversion 1.25 (1.09–1.42)* 1.19 (1.05–1.35)* 1.13 (0.97–1.31) 1.31 (1.06–1.62)* 
Psychoticism 1.05 (0.93–1.20) 1.15 (1.01–1.31)* 1.14 (0.97–1.34) 1.12 (0.89–1.40) 
Lie 0.89 (0.77–1.02) 0.93 (0.82–1.07) 1.01 (0.86–1.19) 1.08 (0.86–1.35) 
*P<0.05, †P<0.01 
OR: odds ratio per 1 SD increase in personality score; CI: confidence interval; MS score: metabolic syndrome score. 
MS score 0: n = 428; MS score 1: n = 393; MS score 2: n = 260; MS score 3: n = 135; MS score 4: n = 79; MS score 5: n = 27. 
The dependent variables were the dichotomized categories of the MS score, and the independent variables were each personality score. 
aAdjusted for age, sex, education, income, smoking status, alcohol use, and family history of cardiovascular disease and diabetes mellitus. 
bThe definition of the metabolic syndrome.
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Table 3. Results of multiple regression analysis for the relationship between each personality score and MS scores 
 Crude  Adjusteda 
 Coefficient (SE) P  Coefficient (SE) P 
Neuroticism –0.12 (0.04) 0.001  –0.03 (0.03) 0.3 
Extraversion 0.16 (0.04) <0.0001  0.12 (0.03) 0.0003 
Psychoticism 0.07 (0.04) 0.046  0.06 (0.03) 0.07 
Lie 0.16 (0.04) <0.0001  –0.03 (0.04) 0.4 
SE: standard error; MS score: metabolic syndrome score. 
Each personality score was standardized to the z-score. 
The dependent variable was MS score and the independent variable was personality score. 
aAdjusted for age, sex, education, income, smoking status, alcohol use, and family history of cardiovascular disease and diabetes mellitus. 
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Table 4. Mean and standard deviation (SD) of each personality score by 
metabolic syndrome components and adjusted odds ratios (ORs) and 95% 
confidence intervals (CIs) for the relationship between each personality score 
and metabolic syndrome components 
 Elevated waist circumferencea 
 
Mean (SD) personality score Adjusted ORb No (n=801) Yes (n=521) P 
Neuroticism 5.5 (3.0) 5.2 (3.0) 0.05 0.92 (0.81–1.03) 
Extraversion 5.4 (3.1) 6.0 (3.1) 0.001 1.20 (1.06–1.36)† 
Psychoticism 2.9 (1.7) 2.8 (1.5) 0.2 1.11 (0.98–1.26) 
Lie 6.1 (2.7) 6.3 (2.7) 0.2 0.83 (0.72–0.94)† 
     
 Elevated triglyceridesa 
 
Mean (SD) personality score Adjusted ORb No (n=1083) Yes (n=239) P 
Neuroticism 5.4 (3.0) 5.1 (3.0) 0.1 0.99 (0.85–1.15) 
Extraversion 5.6 (3.1) 6.1 (3.1) 0.01 1.19 (1.02–1.38)* 
Psychoticism 2.8 (1.6) 2.9 (1.5) 0.4 0.97 (0.83–1.14) 
Lie 6.1 (2.7) 6.6 (2.8) 0.01 1.03 (0.87–1.21) 
     
 Reduced HDL-Ca 
 
Mean (SD) personality score Adjusted ORb No (n=1077) Yes (n=245) P 
Neuroticism 5.4 (3.0) 5.3 (2.9) 0.5 1.02 (0.88–1.18) 
Extraversion 5.6 (3.2) 6.0 (2.9) 0.09 1.06 (0.92–1.23) 
Psychoticism 2.8 (1.6) 2.9 (1.6) 0.5 1.14 (0.97–1.32) 
Lie 6.0 (2.7) 6.8 (2.5) <0.0001 1.13 (0.96–1.33) 
     
 Elevated blood pressurea 
 
Mean (SD) personality score Adjusted ORb No (n=822) Yes (n=500) P 
Neuroticism 5.6 (3.0) 4.9 (3.1) <0.0001 0.88 (0.77–1.00) 
Extraversion 5.5 (3.1) 6.0 (3.1) 0.004 1.16 (1.02–1.33)* 
Psychoticism 2.8 (1.7) 3.0 (1.5) 0.007 1.06 (0.92–1.21) 
Lie 6.0 (2.6) 6.5 (2.7) 0.0005 0.98 (0.85–1.13) 
     
 Elevated fasting glucosea 
 
Mean (SD) personality score Adjusted ORb No (n=1058) Yes (n=264) P 
Neuroticism 5.4 (3.0) 5.2 (3.2) 0.3 1.07 (0.92–1.24) 
Extraversion 5.5 (3.1) 6.2 (3.3) 0.002 1.20 (1.04–1.39)* 
Psychoticism 2.8 (1.6) 3.1 (1.6) 0.0008 1.15 (0.98–1.34) 
Lie 6.1 (2.7) 6.5 (2.7) 0.0502 0.94 (0.80–1.11) 
*P<0.05, †P<0.01 
SD: standard deviation; OR: odds ratio per 1 SD increase; CI: confidence interval; HDL-C: 
high-density lipoprotein cholesterol. 
aElevated waist circumference: ≥90 cm for men, ≥80 cm for women; elevated triglycerides: ≥150 
mg/dL or on drug treatment for elevated triglycerides; reduced HDL-C: <40 mg/dL for men, <50 
mg/dL for women or on drug treatment for reduced HDL-C; elevated blood pressure: ≥130 
mmHg systolic blood pressure or ≥85 mmHg diastolic blood pressure or on antihypertensive 
drug treatment in a patient with a history of hypertension; elevated fasting glucose: ≥100 mg/dL 
or on drug treatment for elevated glucose. 
bIn computing adjusted ORs, the dependent variables were metabolic syndrome components 
(references are those without metabolic syndrome components), and the independent variables 
were each personality score, with adjustment applied for age, sex, education, income, smoking 
status, alcohol use, and family history of cardiovascular disease and diabetes mellitus. 
